Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Introduction
00:00 • 2min
How I Learned the Language of Business
01:30 • 4min
The Difficult Transition to a Science Education
05:22 • 2min
The Origins of Pepdologic
07:33 • 2min
The Therapeutic Potential of Peptides
09:05 • 3min
The Future of Antimicrobial Peptides
11:41 • 5min
Pepthalogics: A Separate Project
16:47 • 3min
The Relationship Between Readily Available Tools and Proprietary Development
20:17 • 2min
The Evolution of Antibiotic Resistance
22:14 • 3min
The Importance of Forward-Looking Statements
25:15 • 5min
Emerging Biotech: Regulation Financing and More
29:59 • 2min
Cloud Card Bex: The Future of Anti-Infectives
31:44 • 2min
Jonathan Steckbeck's Mentality About the End Game for Peptologics
33:22 • 2min
The Unique Opportunity to Commercialize 206
35:02 • 3min
The Lead Horse in the Race: The Hershey Area
37:51 • 2min
Why I Stayed in Pittsburgh
39:54 • 2min
The Procedural Approach to Administration of 206
41:53 • 3min
The Biotech Community in Pittsburgh
45:19 • 2min
The Future of Healthcare
47:06 • 2min
Peptologics' 206 Pipeline Update
49:04 • 2min